Medical News

RSS

Cryoport purchases IP rights to Cryoportal operating platform from Klatu

Cryoport, Inc. today announced the purchase of certain intellectual property and intellectual property rights to the Cryoportal operating platform from KLATU Networks, LLC.

24 Sep 2015

Florida Institute finalizes funding agreement with Aviana

The Florida Institute for the Commercialization of Public Research announced today that it has finalized a funding agreement with Aviana Molecular Technologies, an Orlando-based company with technology developed at the University of Central Florida.

24 Sep 2015

Camber Pharmaceuticals releases generic version of Nexium (Esomeprazole) capsules

Camber Pharmaceuticals is pleased to announce that it has launched Esomeprazole Magnesium Delayed-Release Capsules, 20 mg and 40 mg, which is the generic version of Nexium (Esomeprazole) capsules from AstraZeneca Pharmaceuticals. The product is indicated for the treatment of heartburn, gastroesophageal reflux disease (GERD), stomach ulcers, and for a damaged esophagus.

24 Sep 2015

BD Life Sciences announces FDA clearance for BD MAX Enteric Parasite Panel

BD Life Sciences, a segment of global medical technology company BD (Becton, Dickinson and Company), today announced the availability of the U.S. Food and Drug Administration cleared BD MAX Enteric Parasite Panel for use on the BD MAX System.

From BD (Becton, Dickinson and Company) 24 Sep 2015

Moderate beer consumption protects women from heart attacks

Women who drink beer at most once or twice per week run a 30 per cent lower risk of heart attack, compared with both heavy drinkers and women who never drink beer. These are the findings of a Swedish study which has followed 1,500 women over a period of almost 50 years.

24 Sep 2015

Study compares general and domain-specific measures of self-control to predict consumer behavior

You can resist buying a candy bar while you're waiting in the checkout line at the grocery store--but you'll buy any pair of shoes that are on sale. Your best friend, in contrast, wouldn't dream of buying a pair of shoes he thinks he doesn't need, no matter how low the price--but he can't resist buying that same candy bar you so easily ignore.

24 Sep 2015

Experts raise questions about FDA’s use of expedited development, approval pathways for new drugs

Two studies carried out by US researchers and published by The BMJ today raise questions about whether most new drugs are any more effective than existing products or whether they have been adequately assessed before approval.

24 Sep 2015

Duke Raleigh Hospital becomes first healthcare facility to use certified mobile compounding cleanroom

Duke Raleigh Hospital recently became the first healthcare facility to utilize a certified USP 797 mobile cleanroom to assure uninterrupted pharmacy services. The advanced pharmacy unit, created by Germfree Labs, allowed the hospital to maintain separate, on-site sterile drug compounding operations during a major renovation project.

24 Sep 2015

Pabetalone (RVX-208) to be tested in proof-of-concept pilot study in complement mediated diseases

Resverlogix Corp. announced today the commencement of an Orphan Disease Program specific for Complement Mediated Diseases. New data generated by Resverlogix has demonstrated that BET inhibition by apabetalone (RVX-208) has effects on multiple biological pathways that underlie disease pathology.

24 Sep 2015

Rhythm Metabolic awarded FDA grant to advance ongoing setmelanotide clinical trial in Prader-Willi syndrome

Rhythm announced today the award of a $1 million research grant from the FDA Office of Orphan Products Development to its subsidiary, Rhythm Metabolic, Inc., to support the ongoing Phase 2 clinical trial of setmelanotide, the company's novel peptide MC4 agonist, for the treatment of obesity and hyperphagia in Prader-Willi syndrome (PWS).

24 Sep 2015

Alimera Sciences announces results from ongoing study on ILUVIEN

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced that Alimera Sciences Limited, its European subsidiary based in London, revealed interim six-month data on ILUVIEN (Fluocinolone Acetonide 190 micrograms intravitreal implant in applicator) from the ongoing study referred to as RESPOND, a non-Randomised, open-label, multicenter phase 4 pilot study on the Effect and Safety of ILUVIEN Fluocinolone Acetonide in chronic diabetic macular edema Patients cOnsidered iNsufficiently responsive to available therapies with or without intravitreal corticosteroiD therapy.

24 Sep 2015

ElastiMed raises $1 million investment

ElastiMed, a portfolio company of Trendlines Medical, announced this week that it raised $1 million, which includes an investment from Pix Vine Capital, a Singapore-based investment house.

24 Sep 2015

Men with higher exposure to phthalate have lower sperm motility

Men with higher exposure to the substance DEHP, a so-called phthalate, have lower sperm motility and may therefore experience more difficulties conceiving children, according to a Lund University study.

24 Sep 2015

Researchers reveal potential new treatment methods for fatal brain disease

Researchers from the University of Zurich and the University Hospital Zurich reveal possible new treatment methods for a rare, usually fatal brain disease. Thanks to their discovery that specific antibodies play a key role in combating the viral infection, a vaccine against the disease "progressive multifocal leukoencephalopathy" could now be developed.

24 Sep 2015

Premature infants in intensive care units exposed to a great deal of pain

Premature infants receiving intensive care are exposed to a great deal of pain, and this pain causes damage to the child. Despite this half of the infants admitted to neonatal intensive units will not receive any pain relief, according to a new European study published today in The Lancet Respiratory Medicine.

24 Sep 2015

JRC, CERN to explore potential of accelerator-driven method for producing targeted alpha therapy for cancer

A novel, accelerator-driven method could produce nuclides for targeted alpha therapy of cancer in practically unlimited amounts, overcoming current obstacles for its wider use due to a limited production of alpha-emitters. The JRC and the Conseil Européen pour la Recherche Nucléaire have embarked to explore the potential of the jointly proposed method.

24 Sep 2015

NUS scientists develop novel device suitable for electronics, robotics and healthcare applications

A team of scientists from the National University of Singapore Faculty of Engineering has developed a wearable liquid-based microfluidic tactile sensor that is small, thin, highly flexible and durable. Simple and cost-effective to produce, this novel device is very suitable for applications such as soft robotics, wearable consumer electronics, smart medical prosthetic devices, as well as real-time healthcare monitoring.

24 Sep 2015

Researchers to use big data to improve classification of mood disorders

Mood disorders like depression are common among U.S. adults. Still, such disorders remain challenging for clinicians to diagnose and treat effectively.

24 Sep 2015

Spiritual beliefs may impact physical and mental health, MU study finds

Individuals who blame karma for their poor health have more pain and worse physical and mental health, according to a new study from University of Missouri researchers. Targeted interventions to counteract negative spiritual beliefs could help some individuals decrease pain and improve their overall health, the researchers said.

24 Sep 2015

WSU biomedical students create therapeutic speech development toy for kids with auditory disabilities

Hearing loss is one of the most common birth defects, with more than 12,000 children in the United States affected each year. Three students in Wichita State University's biomedical engineering program recognized this issue and designed their senior project to create a therapeutic toy to provide early intervention therapy for children with auditory disabilities.

24 Sep 2015

Medical News

Cryoport purchases IP rights to Cryoportal operating platform from Klatu

Florida Institute finalizes funding agreement with Aviana

Camber Pharmaceuticals releases generic version of Nexium (Esomeprazole) capsules

BD Life Sciences announces FDA clearance for BD MAX Enteric Parasite Panel

Moderate beer consumption protects women from heart attacks

Study compares general and domain-specific measures of self-control to predict consumer behavior

Experts raise questions about FDA’s use of expedited development, approval pathways for new drugs

Duke Raleigh Hospital becomes first healthcare facility to use certified mobile compounding cleanroom

Pabetalone (RVX-208) to be tested in proof-of-concept pilot study in complement mediated diseases

Rhythm Metabolic awarded FDA grant to advance ongoing setmelanotide clinical trial in Prader-Willi syndrome

Alimera Sciences announces results from ongoing study on ILUVIEN

ElastiMed raises $1 million investment

Men with higher exposure to phthalate have lower sperm motility

Researchers reveal potential new treatment methods for fatal brain disease

Premature infants in intensive care units exposed to a great deal of pain

JRC, CERN to explore potential of accelerator-driven method for producing targeted alpha therapy for cancer

NUS scientists develop novel device suitable for electronics, robotics and healthcare applications

Researchers to use big data to improve classification of mood disorders

Spiritual beliefs may impact physical and mental health, MU study finds

WSU biomedical students create therapeutic speech development toy for kids with auditory disabilities

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News